HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bor-Chyuan Su Selected Research

4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazole

1/2020Pharmacological inhibition of p38 potentiates antimicrobial peptide TP4-induced cell death in glioblastoma cells.
2/2019Antimicrobial Peptide TP4 Induces ROS-Mediated Necrosis by Triggering Mitochondrial Dysfunction in Wild-Type and Mutant p53 Glioblastoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bor-Chyuan Su Research Topics

Disease

5Infections
12/2019 - 01/2017
4Neoplasms (Cancer)
04/2022 - 11/2017
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 02/2019
4Inflammation (Inflammations)
04/2020 - 05/2017
3Necrosis
02/2021 - 04/2013
3Glioblastoma (Glioblastoma Multiforme)
01/2020 - 02/2019
2Synovial Sarcoma (Synovioma)
02/2021 - 03/2020
2Cardiomyopathies (Cardiomyopathy)
03/2020 - 04/2013
2Sepsis (Septicemia)
12/2019 - 12/2017
2Bacterial Infections (Bacterial Infection)
12/2017 - 01/2017
1Esophageal Squamous Cell Carcinoma
04/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Disease Resistance
05/2018
1Endotoxemia
12/2017
1Lung Injury
12/2017
1Cardiotoxicity
04/2013

Drug/Important Bio-Agent (IBA)

8Antimicrobial PeptidesIBA
02/2021 - 12/2017
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 02/2019
3Toll-Like Receptors (Toll-Like Receptor)IBA
04/2020 - 11/2017
2CalciumIBA
02/2021 - 03/2020
24- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
01/2020 - 02/2019
2InterleukinsIBA
03/2018 - 05/2017
2Biological ProductsIBA
03/2018 - 11/2017
2splenotritin (TP3)IBA
03/2018 - 01/2017
2Peptides (Polypeptides)IBA
12/2017 - 01/2017
2Anti-Bacterial Agents (Antibiotics)IBA
12/2017 - 01/2017
2LipopolysaccharidesIBA
12/2017 - 11/2017
2CytokinesIBA
05/2017 - 04/2013
1MicroRNAs (MicroRNA)IBA
04/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1HhAntag691IBA
01/2022
1Calcium Chelating AgentsIBA
02/2021
1lipoteichoic acidIBA
04/2020
1AcidsIBA
04/2020
1CalpainIBA
03/2020
1Proteins (Proteins, Gene)FDA Link
03/2020
1Amino AcidsFDA Link
01/2020
1VX (EDIM)IBA
01/2020
1AntioxidantsIBA
01/2020
1CreatineIBA
12/2019
1Urea (Carbamide)FDA LinkGeneric
12/2019
1Uric Acid (Urate)IBA
12/2019
1NitrogenIBA
12/2019
1Adenosine Monophosphate (AMP)IBA
12/2019
1necrostatin-1IBA
02/2019
1Cyclophilin AIBA
02/2019
1Biomarkers (Surrogate Marker)IBA
02/2019
1Serum Amyloid A Protein (Serum Amyloid A)IBA
05/2018
1fluorescent protein 583IBA
03/2018
1Interleukin-22 (IL-22)IBA
03/2018
1Antimicrobial Cationic PeptidesIBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
05/2017
1Interleukin-10 (Interleukin 10)IBA
05/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2017
1Pharmaceutical PreparationsIBA
01/2017
1Fas Ligand Protein (Fas Ligand)IBA
04/2013
1Extracellular Matrix ProteinsIBA
04/2013

Therapy/Procedure

1Chemoradiotherapy
04/2022
1Oral Administration
05/2018
1Immunomodulation
05/2018
1Ligation
12/2017
1Punctures
12/2017